Vivos Therapeutics
VVOS
VVOS
23 hedge funds and large institutions have $631K invested in Vivos Therapeutics in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.36% less ownership
Funds ownership: 5.5% → 5.14% (-0.36%)
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$65.3K | |
| 2 | +$53.5K | |
| 3 | +$53.5K | |
| 4 |
Millennium Management
New York
|
+$31.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$21.2K |
Top Sellers
| 1 | -$72.5K | |
| 2 | -$6.26K | |
| 3 | -$2.83K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.62K |